Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Change in Inventory: 2020-2025

Historic Change in Inventory for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $882,000.

  • Cellebrite DI's Change in Inventory rose 196.39% to $882,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 27.88%. This contributed to the annual value of -$982,000 for FY2024, which is 304.12% down from last year.
  • Per Cellebrite DI's latest filing, its Change in Inventory stood at $882,000 for Q3 2025, which was up 268.32% from -$524,000 recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Change in Inventory ranged from a high of $1.3 million in Q4 2023 and a low of -$1.7 million during Q4 2021.
  • For the 3-year period, Cellebrite DI's Change in Inventory averaged around $143,000, with its median value being $474,000 (2024).
  • In the last 5 years, Cellebrite DI's Change in Inventory tumbled by 3,563.89% in 2022 and then soared by 312.77% in 2023.
  • Cellebrite DI's Change in Inventory (Quarterly) stood at -$1.7 million in 2021, then skyrocketed by 52.54% to -$812,000 in 2022, then soared by 257.76% to $1.3 million in 2023, then tumbled by 41.76% to $746,000 in 2024, then spiked by 196.39% to $882,000 in 2025.
  • Its Change in Inventory stands at $882,000 for Q3 2025, versus -$524,000 for Q2 2025 and -$10,000 for Q1 2025.